Innoviva (INVA) Gross Margin (2011 - 2026)
Innoviva (INVA) posted Gross Margin of 77.39% for Q1 2026, down 1.03% on a QoQ basis from 78.19% in Q3 2025, and down 533.0% year-over-year from 17.87% in Q1 2025.
Innoviva (INVA) Gross Margin (2011 - 2026) Analysis & Trends
Innoviva's Gross Margin history runs 9 years deep, the most recent figure standing at 77.39% for Q1 2026.
- Quarterly Gross Margin fell 533.0% year-over-year to 77.39% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 93.59% (down 198.0% YoY) and the FY2025 annual result came in at 74.8%, down 778.0% from the prior year.
- Gross Margin was 77.39% for Q1 2026 at Innoviva, down from 78.19% in the prior quarter.
- Across five years, Gross Margin topped out at 2409.3% in Q1 2024 and bottomed at 217.62% in Q2 2023.
- A 5-year average of 237.77% and a median of 82.91% in 2025 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2024 — Gross Margin soared 239593 bps — and 2025, when it sank 232658 bps.
- Innoviva's Gross Margin stood at 98.61% in 2022, then climbed by 1 bps to 99.29% in 2023, then retreated by 18 bps to 81.71% in 2024, then declined by 4 bps to 78.19% in 2025, then dropped by 1 bps to 77.39% in 2026.
- Business Quant data shows INVA's Gross Margin at 77.39% in Q1 2026, 78.19% in Q3 2025, and 82.91% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 88.95% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 77.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.39% |
| Sep 30, 2025 | 78.19% |
| Jun 30, 2025 | 82.91% |
| Mar 31, 2025 | 82.72% |
| Sep 30, 2024 | 81.71% |
| Jun 30, 2024 | 85.07% |
| Mar 31, 2024 | 2,409.30% |
| Sep 30, 2023 | 99.29% |
| Jun 30, 2023 | -217.62% |
| Mar 31, 2023 | 13.37% |
| Sep 30, 2022 | 98.61% |
| Jun 30, 2022 | 100.00% |
| Mar 31, 2022 | 100.00% |
| Sep 30, 2021 | 100.00% |
| Mar 31, 2014 | 75.90% |
| Mar 31, 2013 | 100.00% |
| Dec 31, 2011 | 100.00% |
| Sep 30, 2011 | 100.00% |
| Jun 30, 2011 | 81.58% |